Kodak will manufacture generics for USA

The US government has reached an agreement with Kodak about the production of drugs for the American market. For organization of pharmaceutical production, the company will receive a credit in the amount of 765 million dollars, writes Fortune.

It is expected that the production of drugs in the future will amount to 30-40% of the business by Kodak. As expected, the company will be able to provide 25% of all played active pharmaceutical ingredients in the U.S. market. The production will be organized in the state of new York.

Leave a Reply

Your email address will not be published. Required fields are marked *


Pfizer and Hikma will manufacture ramdevpir

British Hikma announced the start of production of ramdevpir of Gilead, which is currently used for the treatment of patients with COVID-19. A similar agreement for the production of antiretroviral drug Gilead has entered into with Pfizer, writes Reuters. Ramdevpir is one of two drugs that have confirmed efficacy in the treatment of coronavirus infection […]

RNC Pharma: the Russian pharmaceutical manufacturers set an absolute record

The total volume of pharmaceutical production in January-June 2020 reached 232 billion rubles, rate of growth compared to the same period 2019 to 24%, according to the RNC Pharma. Natural dynamics are somewhat more modest: 18.3% packages just for the first half of the domestic companies shipped 2.45 billion packings of medicines. The increase in […]